A recent study by Mao et al.,26 involving an animal model used a combination of oncolytic adenovirus ZD55‐SATB1 to target SATB1 and DTX treatment to effectively inhibit the growth of xenograft tumours; this effect was accompanied by an increase in the expression of caspase protein and a reduction in the expression of CD31. Here, SATB1 is linked to neoplasm.